-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Prevention and Treatment of Adverse Hemostatic Outcomes in Infectious Disease

Program: Scientific Workshops @ ASH
Session: Prevention and Monitoring
Wednesday, December 2, 2020, 8:35 AM-9:35 AM

Jean M. Connors, MD

Brigham & Women's Hospital, Dana Farber Cancer Institute, Boston, MA

Disclosures: Connors: Takeda: Honoraria; CSL Behring: Research Funding; Portola: Honoraria; Bristol-Myers Squibb: Consultancy, Honoraria; Abbott: Consultancy, Honoraria.

See more of: Prevention and Monitoring
See more of: Scientific Workshops @ ASH
Previous Presentation | Next Presentation >>